CLINIMIX 213 mg/100mL

CLINIMIX 213 mg/100mL is an intravenous injection containing essential amino acids. It is designed to support nutritional needs in patients who cannot consume food orally. This product is manufactured by Baxter Healthcare Corporation in the USA.

CLINIMIX 213 mg/100mL is used to provide essential amino acids to patients who require parenteral nutrition. It is often used in clinical settings where oral intake is not possible, such as during surgery recovery or for patients with digestive disorders. This injection helps maintain proper nutritional balance and supports overall health.

The effects of CLINIMIX 213 mg/100mL are primarily related to its role in providing essential amino acids. Patients may experience improved nutritional status and better overall health when used as directed. Common effects include support for muscle maintenance and repair, as well as enhanced recovery from illness or surgery.

CLINIMIX 213 mg/100mL should be used under medical supervision. It is important to follow the instructions provided by a healthcare professional. Patients with certain medical conditions or allergies should inform their healthcare provider before use. Proper storage and handling are essential to maintain the integrity of the product.

CLINIMIX 213 mg/100mL may interact with other medications or supplements. It is important to inform your healthcare provider about all medications you are taking. Certain medications, such as those affecting electrolyte balance, may require monitoring when used with this product. Always consult a healthcare professional for personalized advice.